AI & Real World Data as a Strategic Opportunity for the Pharma Industry and Its Investors - Part 2

On June 28th, Alexandre Templier, President of Quinten AI, delivered a presentation on how his firm works with real-world clinical data. This is part two of the session titled “AI and Real-world Data as a Strategic Opportunity for the Pharma Industry.

8 months ago   •   1 min read

By Dallán Ryan

This content is only available to subscribers

Subscribe now and have access to all our stories, enjoy exclusive content and stay up to date with constant updates.

Sign in now

Spread the word

Keep reading